Cargando…
Anti-cN1A Antibodies Are Associated with More Severe Dysphagia in Sporadic Inclusion Body Myositis
In recent years, an autoantibody directed against the 5′-citosolic nucleotidase1A (cN1A) was identified in the sera of sporadic inclusion body myositis (s-IBM) patients with widely variable sensitivity (33%–76%) and specificity (87%–100%). We assessed the sensitivity/specificity of anti-cN1A antibod...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151681/ https://www.ncbi.nlm.nih.gov/pubmed/34068623 http://dx.doi.org/10.3390/cells10051146 |
_version_ | 1783698440482455552 |
---|---|
author | Lucchini, Matteo Maggi, Lorenzo Pegoraro, Elena Filosto, Massimiliano Rodolico, Carmelo Antonini, Giovanni Garibaldi, Matteo Valentino, Maria Lucia Siciliano, Gabriele Tasca, Giorgio De Arcangelis, Valeria De Fino, Chiara Mirabella, Massimiliano |
author_facet | Lucchini, Matteo Maggi, Lorenzo Pegoraro, Elena Filosto, Massimiliano Rodolico, Carmelo Antonini, Giovanni Garibaldi, Matteo Valentino, Maria Lucia Siciliano, Gabriele Tasca, Giorgio De Arcangelis, Valeria De Fino, Chiara Mirabella, Massimiliano |
author_sort | Lucchini, Matteo |
collection | PubMed |
description | In recent years, an autoantibody directed against the 5′-citosolic nucleotidase1A (cN1A) was identified in the sera of sporadic inclusion body myositis (s-IBM) patients with widely variable sensitivity (33%–76%) and specificity (87%–100%). We assessed the sensitivity/specificity of anti-cN1A antibodies in an Italian cohort of s-IBM patients, searching for a potential correlation with clinical data. We collected clinical data and sera from 62 consecutive s-IBM patients and 62 other inflammatory myopathies patients. Testing for anti-cN1A antibodies was performed using a commercial ELISA. Anti-cN1A antibodies were detected in 23 s-IBM patients, resulting in a sensitivity of 37.1% with a specificity of 96.8%. Positive and negative predictive values were 92.0% and 60.6%, respectively. We did not find significant difference regarding demographic variables, nor quadriceps or finger flexor weakness. Nevertheless, we found that anti-cN1A-positive patients presented significantly lower scores in IBMFRS item 1 (swallowing, p = 0.045) and more frequently reported more severe swallowing problems, expressed as an IBMFRS item 1 score ≤ 2 (p < 0.001). We confirmed the low sensitivity and high specificity of anti-cN1A Ab in s-IBM patients with a high positive predictive value. The presence of anti-CN1A antibodies identified patients with a greater risk of more severe dysphagia. |
format | Online Article Text |
id | pubmed-8151681 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81516812021-05-27 Anti-cN1A Antibodies Are Associated with More Severe Dysphagia in Sporadic Inclusion Body Myositis Lucchini, Matteo Maggi, Lorenzo Pegoraro, Elena Filosto, Massimiliano Rodolico, Carmelo Antonini, Giovanni Garibaldi, Matteo Valentino, Maria Lucia Siciliano, Gabriele Tasca, Giorgio De Arcangelis, Valeria De Fino, Chiara Mirabella, Massimiliano Cells Article In recent years, an autoantibody directed against the 5′-citosolic nucleotidase1A (cN1A) was identified in the sera of sporadic inclusion body myositis (s-IBM) patients with widely variable sensitivity (33%–76%) and specificity (87%–100%). We assessed the sensitivity/specificity of anti-cN1A antibodies in an Italian cohort of s-IBM patients, searching for a potential correlation with clinical data. We collected clinical data and sera from 62 consecutive s-IBM patients and 62 other inflammatory myopathies patients. Testing for anti-cN1A antibodies was performed using a commercial ELISA. Anti-cN1A antibodies were detected in 23 s-IBM patients, resulting in a sensitivity of 37.1% with a specificity of 96.8%. Positive and negative predictive values were 92.0% and 60.6%, respectively. We did not find significant difference regarding demographic variables, nor quadriceps or finger flexor weakness. Nevertheless, we found that anti-cN1A-positive patients presented significantly lower scores in IBMFRS item 1 (swallowing, p = 0.045) and more frequently reported more severe swallowing problems, expressed as an IBMFRS item 1 score ≤ 2 (p < 0.001). We confirmed the low sensitivity and high specificity of anti-cN1A Ab in s-IBM patients with a high positive predictive value. The presence of anti-CN1A antibodies identified patients with a greater risk of more severe dysphagia. MDPI 2021-05-10 /pmc/articles/PMC8151681/ /pubmed/34068623 http://dx.doi.org/10.3390/cells10051146 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lucchini, Matteo Maggi, Lorenzo Pegoraro, Elena Filosto, Massimiliano Rodolico, Carmelo Antonini, Giovanni Garibaldi, Matteo Valentino, Maria Lucia Siciliano, Gabriele Tasca, Giorgio De Arcangelis, Valeria De Fino, Chiara Mirabella, Massimiliano Anti-cN1A Antibodies Are Associated with More Severe Dysphagia in Sporadic Inclusion Body Myositis |
title | Anti-cN1A Antibodies Are Associated with More Severe Dysphagia in Sporadic Inclusion Body Myositis |
title_full | Anti-cN1A Antibodies Are Associated with More Severe Dysphagia in Sporadic Inclusion Body Myositis |
title_fullStr | Anti-cN1A Antibodies Are Associated with More Severe Dysphagia in Sporadic Inclusion Body Myositis |
title_full_unstemmed | Anti-cN1A Antibodies Are Associated with More Severe Dysphagia in Sporadic Inclusion Body Myositis |
title_short | Anti-cN1A Antibodies Are Associated with More Severe Dysphagia in Sporadic Inclusion Body Myositis |
title_sort | anti-cn1a antibodies are associated with more severe dysphagia in sporadic inclusion body myositis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151681/ https://www.ncbi.nlm.nih.gov/pubmed/34068623 http://dx.doi.org/10.3390/cells10051146 |
work_keys_str_mv | AT lucchinimatteo anticn1aantibodiesareassociatedwithmoreseveredysphagiainsporadicinclusionbodymyositis AT maggilorenzo anticn1aantibodiesareassociatedwithmoreseveredysphagiainsporadicinclusionbodymyositis AT pegoraroelena anticn1aantibodiesareassociatedwithmoreseveredysphagiainsporadicinclusionbodymyositis AT filostomassimiliano anticn1aantibodiesareassociatedwithmoreseveredysphagiainsporadicinclusionbodymyositis AT rodolicocarmelo anticn1aantibodiesareassociatedwithmoreseveredysphagiainsporadicinclusionbodymyositis AT antoninigiovanni anticn1aantibodiesareassociatedwithmoreseveredysphagiainsporadicinclusionbodymyositis AT garibaldimatteo anticn1aantibodiesareassociatedwithmoreseveredysphagiainsporadicinclusionbodymyositis AT valentinomarialucia anticn1aantibodiesareassociatedwithmoreseveredysphagiainsporadicinclusionbodymyositis AT sicilianogabriele anticn1aantibodiesareassociatedwithmoreseveredysphagiainsporadicinclusionbodymyositis AT tascagiorgio anticn1aantibodiesareassociatedwithmoreseveredysphagiainsporadicinclusionbodymyositis AT dearcangelisvaleria anticn1aantibodiesareassociatedwithmoreseveredysphagiainsporadicinclusionbodymyositis AT definochiara anticn1aantibodiesareassociatedwithmoreseveredysphagiainsporadicinclusionbodymyositis AT mirabellamassimiliano anticn1aantibodiesareassociatedwithmoreseveredysphagiainsporadicinclusionbodymyositis |